Altimmune报告减重药物试验积极结果

Reported 8 months ago

Altimmune（ALT）跨国生物制药公司报告其减重药物pemvidutide的二期试验取得积极结果。雅虎财经健康记者Anjalee Khemlani解释了试验结果，包括参与者记录的瘦体重损失数据。了解更多专家见解和最新市场动态，请点击此处观看Market Domination的完整剧集。

You may also interested in these wikis

BHM Spotlight: CEO Fawn Weaver's Inspiring Journey

Salesforce CEO Marc Benioff Remains Optimistic Despite Guidance Miss

Gold Set for Weekly Decline as Trump Tariff Concerns Strengthen Dollar

Oil Prices Set for First Monthly Drop Since November Amid Economic Uncertainty

Americans Set to Receive Increased Social Security Payments

Salesforce's Disappointing Fiscal Outlook Raises Doubts on AI Product

Foreign Workers Fuel Spain's Economic Growth, Surpassing the US and Europe

China's Manufacturing Activity Likely to Contract Again in February: Reuters Poll

U.S. Securities Regulator Moves to Dismiss Lawsuit Against Coinbase

Nvidia Reports Significant Sales Growth in Q4 Driven by AI Chip Demand

Back to all Wikis